StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Hepion Pharmaceuticals's enterprise value was $1.34M on Oct 19, 2026, against -$2.15M a year earlier. Over the last 5 years it ranged from -$38.06M to $15.44M, with a median of -$2.34M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.34M–
2025Dec 31, 2025-$1.62M-191.5%
2024Dec 31, 2024$1.77M–
2023Dec 29, 2023-$6.85M–
2022Dec 30, 2022-$36.28M–
2021Dec 31, 2021-$11.83M-295.5%
2020Dec 31, 2020$6.05M+65.9%
2019Dec 31, 2019$3.65M–
2018Dec 31, 2018-$10.32M-172.5%
2017Dec 29, 2017$14.23M-77.6%
2016Dec 30, 2016$63.50M+94.2%
2015Dec 31, 2015$32.70M-33.2%
2014Dec 31, 2014$48.99M–

More Hepion Pharmaceuticals figures

See a number that looks wrong?